Related Experiment Video
Updated: Aug 18, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Anaesthesia for adults with cystic fibrosis
1Alfred Group of Hospitals, Prahran, Victoria.
Insights
Cystic fibrosis (CF) patients, even with severe respiratory issues, can undergo procedures safely with careful anesthetic management. Optimal pre- and postoperative care, focusing on airway clearance, is crucial for minimizing risks in CF patients.
Area of Science:
- Anesthesiology
- Pulmonology
- Genetics
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organ systems, primarily the lungs and gastrointestinal tract.
- Increased survival of CF patients into adulthood necessitates specialized anesthetic care for various procedures.
- Common CF complications like severe respiratory disease, diabetes, and reflux pose challenges for anesthesiologists.
Purpose of the Study:
- To describe the anesthetic management and perioperative care of cystic fibrosis patients.
- To evaluate the safety and outcomes of surgical procedures in CF patients.
- To highlight the importance of multidisciplinary care for cystic fibrosis patients undergoing anesthesia.
Main Methods:
- Retrospective cohort study of 74 cystic fibrosis patients undergoing 149 procedures.
- Data collected from January 1978 to January 1994 at Alfred Hospital.
- Analysis of anesthetic techniques and perioperative management strategies.
Main Results:
- Overall mortality was 0.6% for all procedures and 1% for postoperative mortality.
- Procedures included CF-related interventions (diagnostic, venous access, feeding tubes, complication management, lung transplantation) and unrelated conditions.
- Patients with compromised respiratory function were managed with acceptable low mortality.
Conclusions:
- Cystic fibrosis patients can undergo surgical procedures with low mortality when managed with appropriate anesthetic and perioperative strategies.
- Effective clearance of respiratory secretions is paramount in pre- and postoperative care.
- Careful planning and a multidisciplinary team approach are essential for optimal outcomes in cystic fibrosis patients.
Abstract:
Cystic fibrosis is an autosomal recessive disorder which affects one in 2500 live births. It is a multisystem disease and has a variety of presentations. The major clinical features affect the gastrointestinal and respiratory tracts. Severe respiratory disease, diabetes and gastroesophageal reflux are common features of concern to anaesthetists. Improved care of young patients has allowed many to survive into adulthood. Lung transplantation has significantly improved the outlook for many patients. At Alfred Hospital, 74 patients with cystic fibrosis underwent 149 procedures from January 1978 to January 1994, with a mortality of 0.6% (95% CI 0.4%-0.8%). This retrospective cohort study describes the anaesthetic management and perioperative care of these patients. Most of the anaesthetics were for procedures related to cystic fibrosis but 12% were for unrelated conditions. Cystic fibrosis related procedures include diagnostic, venous access, enteral feeding procedures, treatment of complications of cystic fibrosis and lung transplantation. Despite extremely poor respiratory function, these patients can be managed with acceptably low postoperative mortality (1%). Pre- and postoperative care must be directed towards optimal clearance of viscous respiratory secretions. Procedures need to be planned so that optimal care can be given by each member of the team caring for cystic fibrosis patients.
Related Concept Videos
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...

